{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:17:11Z","timestamp":1780957031948,"version":"3.54.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s40801-022-00321-7","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T19:02:32Z","timestamp":1658170952000},"page":"503-516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Associations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, Norway"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-7536","authenticated-orcid":false,"given":"Ivana","family":"Bojani\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottar","family":"Bjerkeset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik R.","family":"Sund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Sletvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"issue":"11","key":"321_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11): e442. https:\/\/doi.org\/10.1371\/journal.pmed.0030442.","journal-title":"PLoS Med"},{"key":"321_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381. https:\/\/doi.org\/10.1016\/j.diabres.2018.02.023.","journal-title":"Diabetes Res Clin Pract"},{"key":"321_CR3","unstructured":"World Health Organization. Global health estimates: life expectancy and leading causes of death and disability. 2019. https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates. Accessed 20 Sep 2021."},{"issue":"4","key":"321_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.genhosppsych.2007.03.009","volume":"29","author":"J Ormel","year":"2007","unstructured":"Ormel J, Von Korff M, Burger H, et al. Mental disorders among persons with heart disease: results from world mental health surveys. Gen Hosp Psychiatry. 2007;29(4):325\u201334. https:\/\/doi.org\/10.1016\/j.genhosppsych.2007.03.009.","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"321_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10654-009-9385-0","volume":"24","author":"S Aarts","year":"2009","unstructured":"Aarts S, van den Akker M, van Boxtel MPJ, Jolles J, Winkens B, Metsemakers JFM. Diabetes mellitus type II as a risk factor for depression: a lower than expected risk in a general practice setting. Eur J Epidemiol. 2009;24(10):641\u20138. https:\/\/doi.org\/10.1007\/s10654-009-9385-0.","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"321_CR6","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1161\/CIR.0000000000000019","volume":"129","author":"JH Lichtman","year":"2014","unstructured":"Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350\u201369.","journal-title":"Circulation"},{"issue":"7","key":"321_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.2337\/diacare.23.7.934","volume":"23","author":"PJ Lustman","year":"2000","unstructured":"Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23(7):934\u201342. https:\/\/doi.org\/10.2337\/diacare.23.7.934.","journal-title":"Diabetes Care"},{"issue":"4","key":"321_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jpsychores.2006.12.009","volume":"62","author":"L Stafford","year":"2007","unstructured":"Stafford L, Berk M, Reddy P, Jackson HJ. Comorbid depression and health-related quality of life in patients with coronary artery disease. J Psychosom Res. 2007;62(4):401\u201310. https:\/\/doi.org\/10.1016\/j.jpsychores.2006.12.009.","journal-title":"J Psychosom Res"},{"issue":"5","key":"321_CR9","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.2337\/diacare.27.5.1066","volume":"27","author":"RD Goldney","year":"2004","unstructured":"Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care. 2004;27(5):1066\u201370. https:\/\/doi.org\/10.2337\/diacare.27.5.1066.","journal-title":"Diabetes Care"},{"issue":"3","key":"321_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/s0165-0327(01)00413-x","volume":"72","author":"P Cuijpers","year":"2002","unstructured":"Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord. 2002;72(3):227\u201336. https:\/\/doi.org\/10.1016\/s0165-0327(01)00413-x.","journal-title":"J Affect Disord"},{"key":"321_CR11","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/S0165-0327(12)70008-3","volume":"142","author":"I Molosankwe","year":"2012","unstructured":"Molosankwe I, Patel A, Jos\u00e9 Gagliardino J, Knapp M, McDaid D. Economic aspects of the association between diabetes and depression: a systematic review. J Affect Disord. 2012;142:S42-55. https:\/\/doi.org\/10.1016\/S0165-0327(12)70008-3.","journal-title":"J Affect Disord"},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychores.2017.10.015","volume":"104","author":"J Palacios","year":"2018","unstructured":"Palacios J, Khondoker M, Mann A, Tylee A, Hotopf M. Depression and anxiety symptom trajectories in coronary heart disease: associations with measures of disability and impact on 3-year health care costs. J Psychosom Res. 2018;104:1\u20138. https:\/\/doi.org\/10.1016\/j.jpsychores.2017.10.015.","journal-title":"J Psychosom Res"},{"issue":"34","key":"321_CR13","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u201337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484.","journal-title":"Eur Heart J"},{"issue":"1","key":"321_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.31887\/DCNS.2018.20.1\/nsartorius","volume":"20","author":"N Sartorius","year":"2018","unstructured":"Sartorius N. Depression and diabetes. Dialog Clin Neurosci. 2018;20(1):47\u201352.","journal-title":"Dialog Clin Neurosci"},{"issue":"3","key":"321_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/01.CIR.0000154573.62822.89","volume":"111","author":"JS Rumsfeld","year":"2005","unstructured":"Rumsfeld JS, Ho PM. Depression and cardiovascular disease. Circulation. 2005;111(3):250\u20133. https:\/\/doi.org\/10.1161\/01.CIR.0000154573.62822.89.","journal-title":"Circulation"},{"issue":"2","key":"321_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pec.2005.01.009","volume":"60","author":"F Pouwer","year":"2006","unstructured":"Pouwer F, Beekman ATF, Lubach C, Snoek FJ. Nurses\u2019 recognition and registration of depression, anxiety and diabetes-specific emotional problems in outpatients with diabetes mellitus. Patient Educ Counsel. 2006;60(2):235\u201340. https:\/\/doi.org\/10.1016\/j.pec.2005.01.009.","journal-title":"Patient Educ Counsel."},{"issue":"4","key":"321_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3949\/ccjm.73.4.351","volume":"73","author":"EA Khawam","year":"2006","unstructured":"Khawam EA, Laurencic G, Malone DA Jr. Side effects of antidepressants: an overview. Cleve Clin J Med. 2006;73(4):351\u20133. https:\/\/doi.org\/10.3949\/ccjm.73.4.351 (6\u201361).","journal-title":"Cleve Clin J Med"},{"issue":"5","key":"321_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1586\/14737175.2014.908709","volume":"14","author":"R Mago","year":"2014","unstructured":"Mago R, Tripathi N, Andrade C. Cardiovascular adverse effects of newer antidepressants. Expert Rev Neurother. 2014;14(5):539\u201351.","journal-title":"Expert Rev Neurother"},{"issue":"9","key":"321_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2165\/11533280-000000000-00000","volume":"24","author":"RS McIntyre","year":"2010","unstructured":"McIntyre RS, Park KY, Law CWY, et al. The association between conventional antidepressants and the metabolic syndrome. CNS Drugs. 2010;24(9):741\u201353. https:\/\/doi.org\/10.2165\/11533280-000000000-00000.","journal-title":"CNS Drugs"},{"issue":"4","key":"321_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/hco.0000000000000297","volume":"31","author":"AA Oktay","year":"2016","unstructured":"Oktay AA, Akturk HK, Jahangir E. Diabetes mellitus and hypertension: a dual threat. Curr Opin Cardiol. 2016;31(4):402\u20139. https:\/\/doi.org\/10.1097\/hco.0000000000000297.","journal-title":"Curr Opin Cardiol"},{"issue":"23","key":"321_CR21","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Aguilar D, Deswal A, et al. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e535\u201378. https:\/\/doi.org\/10.1161\/CIR.0000000000000450.","journal-title":"Circulation"},{"key":"321_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.neubiorev.2016.07.003","volume":"74","author":"BWJH Penninx","year":"2017","unstructured":"Penninx BWJH. Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017;74:277\u201386. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.07.003.","journal-title":"Neurosci Biobehav Rev"},{"key":"321_CR23","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0165-0327(12)70004-6","volume":"142","author":"T Roy","year":"2012","unstructured":"Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142:S8-21. https:\/\/doi.org\/10.1016\/S0165-0327(12)70004-6.","journal-title":"J Affect Disord"},{"key":"321_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109720","volume":"95","author":"RB Grigolon","year":"2019","unstructured":"Grigolon RB, Brietzke E, Mansur RB, et al. Association between diabetes and mood disorders and the potential use of anti-hyperglycemic agents as antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 2019;95: 109720. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109720.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"321_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2174\/1389200219666180305143501","volume":"19","author":"P Zuzarte","year":"2018","unstructured":"Zuzarte P, Duong A, Figueira ML, Costa-Vitali A, Scola G. Current therapeutic approaches for targeting inflammation in depression and cardiovascular disease. Curr Drug Metab. 2018;19(8):674\u201387. https:\/\/doi.org\/10.2174\/1389200219666180305143501.","journal-title":"Curr Drug Metab"},{"issue":"1","key":"321_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1741-7015-10-151","volume":"10","author":"M Berk","year":"2012","unstructured":"Berk M. Pathways to new drug discovery in neuropsychiatry. BMC Med. 2012;10(1):151. https:\/\/doi.org\/10.1186\/1741-7015-10-151.","journal-title":"BMC Med"},{"issue":"1","key":"321_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12916-017-0916-3","volume":"15","author":"J Vian","year":"2017","unstructured":"Vian J, Pereira C, Chavarria V, et al. The renin-angiotensin system: a possible new target for depression. BMC Med. 2017;15(1):144. https:\/\/doi.org\/10.1186\/s12916-017-0916-3.","journal-title":"BMC Med"},{"issue":"1","key":"321_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/acps.12957","volume":"139","author":"LV Kessing","year":"2019","unstructured":"Kessing LV, Rytgaard HC, Gerds TA, Berk M, Ekstr\u00f8m CT, Andersen PK. New drug candidates for depression - a nationwide population-based study. Acta Psychiatr Scand. 2019;139(1):68\u201377. https:\/\/doi.org\/10.1111\/acps.12957.","journal-title":"Acta Psychiatr Scand"},{"key":"321_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fpsyt.2019.00103","volume":"10","author":"S-W Kim","year":"2019","unstructured":"Kim S-W, Kang H-J, Jhon M, et al. Statins and inflammation: new therapeutic opportunities in psychiatry. Front Psychiatry. 2019;10:103. https:\/\/doi.org\/10.3389\/fpsyt.2019.00103.","journal-title":"Front Psychiatry."},{"issue":"6","key":"321_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/pds.5011","volume":"29","author":"H-B Kim","year":"2020","unstructured":"Kim H-B, Kim J-S, Jung J-G. The association between aspirin use and depression: a systematic review and meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2020;29(6):613\u201322. https:\/\/doi.org\/10.1002\/pds.5011.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"321_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12916-019-1475-6","volume":"18","author":"M Berk","year":"2020","unstructured":"Berk M, Mohebbi M, Dean OM, et al. Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin. BMC Med. 2020;18(1):16. https:\/\/doi.org\/10.1186\/s12916-019-1475-6.","journal-title":"BMC Med"},{"key":"321_CR32","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s13311-020-00878-7","volume":"17","author":"MS Abdallah","year":"2020","unstructured":"Abdallah MS, Mosalam EM, Zidan A-AA, et al. The antidiabetic metformin as an adjunct to antidepressants in patients with major depressive disorder: a proof-of-concept, randomized, double-blind, placebo-controlled trial. Neurotherapeutics. 2020;17:1897\u2013906.","journal-title":"Neurotherapeutics"},{"issue":"5","key":"321_CR33","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/hypertensionaha.116.08188","volume":"68","author":"AH Boal","year":"2016","unstructured":"Boal AH, Smith DJ, McCallum L, et al. Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders. Hypertension. 2016;68(5):1132\u20138. https:\/\/doi.org\/10.1161\/hypertensionaha.116.08188.","journal-title":"Hypertension"},{"issue":"4","key":"321_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10571-011-9656-7","volume":"31","author":"SJ Nasr","year":"2011","unstructured":"Nasr SJ, Crayton JW, Agarwal B, Wendt B, Kora R. Lower frequency of antidepressant use in patients on renin-angiotensin-aldosterone system modifying medications. Cell Mol Neurobiol. 2011;31(4):615\u20138.","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"321_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/0004867417721654","volume":"52","author":"DJ Brownstein","year":"2018","unstructured":"Brownstein DJ, Salagre E, K\u00f6hler C, et al. Blockade of the angiotensin system improves mental health domain of quality of life: a meta-analysis of randomized clinical trials. Aust N Z J Psychiatry. 2018;52(1):24\u201338. https:\/\/doi.org\/10.1177\/0004867417721654.","journal-title":"Aust N Z J Psychiatry"},{"issue":"11","key":"321_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41371-020-0303-y","volume":"34","author":"B Agustini","year":"2020","unstructured":"Agustini B, Mohebbi M, Woods RL, et al. The association of antihypertensive use and depressive symptoms in a large older population with hypertension living in Australia and the United States: a cross-sectional study. J Hum Hypertens. 2020;34(11):787\u201394.","journal-title":"J Hum Hypertens"},{"issue":"7","key":"321_CR37","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1017\/S0033291719004094","volume":"51","author":"RJ Shaw","year":"2021","unstructured":"Shaw RJ, Mackay D, Pell JP, Padmanabhan S, Bailey DS, Smith DJ. The relationship between antihypertensive medications and mood disorders: analysis of linked healthcare data for 1.8 million patients. Psychol Med. 2021;51(7):1183\u201391. https:\/\/doi.org\/10.1017\/S0033291719004094.","journal-title":"Psychol Med"},{"issue":"4","key":"321_CR38","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.120.15605","volume":"76","author":"LV Kessing","year":"2020","unstructured":"Kessing LV, Rytgaard HC, Ekstr\u00f8m CT, Torp-Pedersen C, Berk M, Gerds TA. Antihypertensive drugs and risk of depression: a nationwide population-based study. Hypertension. 2020;76(4):1263\u201379.","journal-title":"Hypertension"},{"key":"321_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jad.2019.07.002","volume":"257","author":"MS Yatham","year":"2019","unstructured":"Yatham MS, Yatham KS, Ravindran AV, Sullivan F. Do statins have an effect on depressive symptoms? A systematic review and meta-analysis. J Affect Disord. 2019;257:55\u201363. https:\/\/doi.org\/10.1016\/j.jad.2019.07.002.","journal-title":"J Affect Disord"},{"issue":"1","key":"321_CR40","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1186\/s12889-019-7392-y","volume":"19","author":"F Chen","year":"2019","unstructured":"Chen F, Wei G, Wang Y, et al. Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition. BMC Public Health. 2019;19(1):1063. https:\/\/doi.org\/10.1186\/s12889-019-7392-y.","journal-title":"BMC Public Health"},{"issue":"12","key":"321_CR41","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.2337\/dc20-1561","volume":"43","author":"LV Kessing","year":"2020","unstructured":"Kessing LV, Rytgaard HC, Ekstr\u00f8m CT, Knop FK, Berk M, Gerds TA. Antidiabetes agents and incident depression: a nationwide population-based study. Diabetes Care. 2020;43(12):3050\u201360. https:\/\/doi.org\/10.2337\/dc20-1561.","journal-title":"Diabetes Care"},{"issue":"4","key":"321_CR42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jdiacomp.2017.01.013","volume":"31","author":"CP Wang","year":"2017","unstructured":"Wang CP, Lorenzo C, Habib SL, Jo B, Espinoza SE. Differential effects of metformin on age related comorbidities in older men with type 2 diabetes. J Diabetes Complications. 2017;31(4):679\u201386. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.01.013.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"321_CR43","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1741-7015-10-150","volume":"10","author":"ML Wahlqvist","year":"2012","unstructured":"Wahlqvist ML, Lee MS, Chuang SY, et al. Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study. BMC Med. 2012;10(1):150. https:\/\/doi.org\/10.1186\/1741-7015-10-150.","journal-title":"BMC Med"},{"key":"321_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.psyneuen.2018.05.010","volume":"94","author":"CD Moulton","year":"2018","unstructured":"Moulton CD, Hopkins CWP, Ismail K, Stahl D. Repositioning of diabetes treatments for depressive symptoms: a systematic review and meta-analysis of clinical trials. Psychoneuroendocrinology. 2018;94:91\u2013103. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.05.010.","journal-title":"Psychoneuroendocrinology"},{"key":"321_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyac095","author":"BO \u00c5svold","year":"2022","unstructured":"\u00c5svold BO, Langhammer A, Rehn TA, et al. Cohort profile update: the HUNT Study, Norway. medRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.10.12.21264858.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"321_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4088\/JCP.10m06176blu","volume":"72","author":"F Lamers","year":"2011","unstructured":"Lamers F, van Oppen P, Comijs HC, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011;72(3):341\u20138. https:\/\/doi.org\/10.4088\/JCP.10m06176blu.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"321_CR47","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/01.psy.0000145823.85658.0c","volume":"66","author":"TT Haug","year":"2004","unstructured":"Haug TT, Mykletun A, Dahl AA. The association between anxiety, depression, and somatic symptoms in a large population: the HUNT-II Study. Psychosom Med. 2004;66(6):845\u201351.","journal-title":"Psychosom Med"},{"issue":"2","key":"321_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52(2):69\u201377. https:\/\/doi.org\/10.1016\/S0022-3999(01)00296-3.","journal-title":"J Psychosom Res"},{"issue":"5","key":"321_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.genhosppsych.2007.06.005","volume":"29","author":"L Stafford","year":"2007","unstructured":"Stafford L, Berk M, Jackson HJ. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry. 2007;29(5):417\u201324. https:\/\/doi.org\/10.1016\/j.genhosppsych.2007.06.005.","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"321_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jad.2009.09.022","volume":"123","author":"S Sultan","year":"2010","unstructured":"Sultan S, Luminet O, Hartemann A. Cognitive and anxiety symptoms in screening for clinical depression in diabetes: a systematic examination of diagnostic performances of the HADS and BDI-SF. J Affect Disord. 2010;123(1):332\u20136. https:\/\/doi.org\/10.1016\/j.jad.2009.09.022.","journal-title":"J Affect Disord"},{"issue":"1","key":"321_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12955-017-0759-9","volume":"15","author":"I Djukanovic","year":"2017","unstructured":"Djukanovic I, Carlsson J, \u00c5restedt K. Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65\u201380 years old? A psychometric evaluation study. Health Qual Life Outcomes. 2017;15(1):193. https:\/\/doi.org\/10.1186\/s12955-017-0759-9.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"321_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, S\u00f8rensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106(2):86\u201394. https:\/\/doi.org\/10.1111\/j.1742-7843.2009.00494.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"321_CR53","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology 2021. https:\/\/www.who.int\/medicines\/regulation\/medicines-safety\/about\/collab-centres-norwegian\/en\/. Accessed 9 Jul 2022."},{"key":"321_CR54","unstructured":"World Health Organization. Obesity and overweight. 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed 18 Jul 2021."},{"issue":"3","key":"321_CR55","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/02813430310002030","volume":"21","author":"E Stordal","year":"2003","unstructured":"Stordal E, Bjelland I, Dahl AA, Mykletun A. Anxiety and depression in individuals with somatic health problems: the Nord-Tr\u00f8ndelag Health Study (HUNT). Scand J Prim Health Care. 2003;21(3):136\u201341. https:\/\/doi.org\/10.1080\/02813430310002030.","journal-title":"Scand J Prim Health Care"},{"issue":"6516","key":"321_CR56","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/bmj.292.6516.344","volume":"292","author":"RP Snaith","year":"1986","unstructured":"Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed). 1986;292(6516):344. https:\/\/doi.org\/10.1136\/bmj.292.6516.344.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"321_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jad.2013.11.026","volume":"160","author":"AK Parsaik","year":"2014","unstructured":"Parsaik AK, Singh B, Murad MH, et al. Statins use and risk of depression: a systematic review and meta-analysis. J Affect Disord. 2014;160:62\u20137. https:\/\/doi.org\/10.1016\/j.jad.2013.11.026.","journal-title":"J Affect Disord"},{"issue":"1","key":"321_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-014-0348-y","volume":"14","author":"C Redlich","year":"2014","unstructured":"Redlich C, Berk M, Williams LJ, Sundquist J, Sundquist K, Li X. Statin use and risk of depression: a Swedish national cohort study. BMC Psychiatry. 2014;14(1):1\u20139.","journal-title":"BMC Psychiatry"},{"key":"321_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2017.05.105","volume":"246","author":"IK Wium-Andersen","year":"2017","unstructured":"Wium-Andersen IK, Wium-Andersen MK, J\u00f8rgensen MB, Osler M. Anti-inflammatory treatment and risk of depression in 91,842 patients with acute coronary syndrome and 91,860 individuals without acute coronary syndrome in Denmark. Int J Cardiol. 2017;246:1\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2017.05.105.","journal-title":"Int J Cardiol"},{"issue":"9","key":"321_CR60","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1038\/s41380-021-01020-5","volume":"26","author":"M Berk","year":"2021","unstructured":"Berk M, Agustini B, Woods RL, et al. Effects of aspirin on the long-term management of depression in older people: a double-blind randomized placebo-controlled trial. Mol Psychiatry. 2021;26(9):5161\u201370. https:\/\/doi.org\/10.1038\/s41380-021-01020-5.","journal-title":"Mol Psychiatry"},{"issue":"10","key":"321_CR61","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/jamapsychiatry.2020.1214","volume":"77","author":"M Berk","year":"2020","unstructured":"Berk M, Woods RL, Nelson MR, et al. Effect of aspirin vs placebo on the prevention of depression in older people: a randomized clinical trial. JAMA Psychiat. 2020;77(10):1012\u201320. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.1214.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"321_CR62","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40359-021-00636-0","volume":"9","author":"I Bojani\u0107","year":"2021","unstructured":"Bojani\u0107 I, Sund ER, Sletvold H, Bjerkeset O. Prevalence trends of depression and anxiety symptoms in adults with cardiovascular diseases and diabetes 1995\u20132019: the HUNT studies, Norway. BMC Psychol. 2021;9(1):130. https:\/\/doi.org\/10.1186\/s40359-021-00636-0.","journal-title":"BMC Psychol."},{"issue":"9","key":"321_CR63","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s00127-007-0225-9","volume":"42","author":"A Bramesfeld","year":"2007","unstructured":"Bramesfeld A, Grobe T, Schwartz FW. Who is treated, and how, for depression? Soc Psychiatry Psychiatr Epidemiol. 2007;42(9):740\u20136. https:\/\/doi.org\/10.1007\/s00127-007-0225-9.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"7","key":"321_CR64","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s40263-019-00633-3","volume":"33","author":"B Agustini","year":"2019","unstructured":"Agustini B, Mohebbi M, Woods RL, et al. Association between statin use and depressive symptoms in a large community-dwelling older population living in Australia and the USA: a cross-sectional study. CNS Drugs. 2019;33(7):685\u201394. https:\/\/doi.org\/10.1007\/s40263-019-00633-3.","journal-title":"CNS Drugs"},{"issue":"9","key":"321_CR65","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/pds.1993","volume":"19","author":"L Feng","year":"2010","unstructured":"Feng L, Yap KB, Kua EH, Ng TP. Statin use and depressive symptoms in a prospective study of community-living older persons. Pharmacoepidemiol Drug Saf. 2010;19(9):942\u20138. https:\/\/doi.org\/10.1002\/pds.1993.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"321_CR66","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00228-014-1677-y","volume":"70","author":"A Potteg\u00e5rd","year":"2014","unstructured":"Potteg\u00e5rd A, Christensen RD, Houji A, et al. Primary non-adherence in general practice: a Danish register study. Eur J Clin Pharmacol. 2014;70(6):757\u201363. https:\/\/doi.org\/10.1007\/s00228-014-1677-y.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"321_CR67","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00228-007-0301-9","volume":"63","author":"K Furu","year":"2007","unstructured":"Furu K, Skurtveit S, Langhammer A, Nafstad P. Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis. Eur J Clin Pharmacol. 2007;63(7):693\u20138.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-022-00321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-022-00321-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-022-00321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T04:20:07Z","timestamp":1660969207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-022-00321-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1007\/s40801-022-00321-7","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"22 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the Faculty of Nursing and Health Sciences at Nord University, Nord. The funding body had no role in the design of the study, analysis and interpretation of the data, or writing of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Ivana Bojani\u0107, Ottar Bjerkeset, Lana J. Williams, Michael Berk, Erik R. Sund, and Hege Sletvold have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"This study was approved by the Regional Committees for Medical Research and Health Research Ethics in Norway (reference 2019\/30292\/REK Nord) and the Norwegian Centre for Research Data (reference 30292\/NSD). All study methods were carried out following the institutional guidelines and according to the ethical standards in human research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All HUNT participants were informed about the study and gave their informed consent to participate and this consent included the use of the data material in the future.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data used in this study are available from the HUNT databank, but restrictions apply to the availability of these data. The data were used under license for the current study and thus are not publicly available. However, data are available from the authors upon reasonable request and with permission from HUNT, The Regional Ethical Committee, and Norwegian Data Protection Authority. The dataset used in this study are stored in the HUNT databank using a personal identification number given to all Norwegians at birth or immigration as a key identification. The HUNT Research Centre has permission from the Norwegian Data Inspectorate to store and handle these data. The HUNT data are available for scientists who wish to use them for research and non-commercial purposes without breaching participant confidentiality. The researcher will always receive an anonymous or \u201cde-identified\u201d dataset after receiving approval of a research protocol by the Regional Ethical Committee and the HUNT Research Centre. To protect participants\u2019 privacy, the HUNT Research Centre aims to limit data storage outside the HUNT databank and cannot deposit data in open repositories. The HUNT databank has precise information on all data exported to different projects and can reproduce these on request. There are no restrictions regarding data export to give approval of applications to HUNT Research. For more information about HUNT data, see <b>.<\/b>","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed substantially to the conceptualization, design of the study, and writing of the manuscript. IB performed the statistical analysis in collaboration with ERS. All authors contributed to the interpretation of the results of the analysis. IB wrote the article\u2019s first draft, and HS, OB, LJW, MB, and ERS critically revised the content. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u02b9 contributions"}}]}}